Objectives of the CRT meeting
To establish a comprehensive and actionable roadmap for the trustworthy implementation of AI into clinical practice within cardiology, ensuring that AI tools are reliable, evidence-based, and contribute to improved patient outcomes. This roadmap will be developed through collaboration between the medical industry, regulators, notified bodies, professional societies, policy makers, payers and patient representatives. Insights and findings from the meeting will be summarised and distributed via academic publications including a white paper and industry reports.
Objectives of the 2nd CRT on AI meeting:
- How can cardiologists transition from a reactive position to a proactive role and lead the development of AI?
- Create a platform to bring together diverse expertise, spark innovation, and create actionable plans to move the field of AI in cardiology forward.
- Identify and address critical challenges in advancing AI applications development and implementation in cardiology.
Objectives of the 2nd CRT on AI meeting:
- Presentation of four projects to be launched and accomplished in one year.
Co-Chairs
Academic Chairpersons
- Prof. Folkert Asselbergs
- Prof. Ruben Casado Arroyo
- Prof. Cecilia Linde (ESC President-Elect and ESC Chair of the CRT)
Industry Chairpersons
- Dr. Katarzyna Markiewicz /Philips
- Prof. Rodolphe Katra /Medtronic
- Prof. Alexandra Goncalves /BMS (Industry Chair of the CRT)
Day 1: 26 March 2025 11:30–19:15 CEST
Time and Session |
11:30-15:50-SESSION 1 MODERATED BY: Ruben Casado Arroyo and Katarzyna Markiewicz (Philips) |
Time and Session |
11:30-11:35 Welcome from the CRT Chairpersons |
Speakers |
Alexandra Goncalves (BMS) Cecilia Linde |
Time and Session |
11:35-11:45 Summary of the previous meeting on AI |
Speakers |
Ruben Casado Arroyo Katarzyna Markiewicz (Philips) |
Time and Session |
11:45-12:00 Agenda overview and expected outcomes |
Speakers |
Guy Spigelman (Amazon Web Services) & meeting facilitator Folkert Asselbergs |
Time and Session |
12:10-12:30 What are the requirements for evidence generation of AI models to be guideline proof? |
Speakers | Rohan Khera |
Time and Session |
12:30-13:30 Buffet Lunch |
Time and Session |
13:30-14:30 BREAKOUT SESSIONS : BRAINSTORM ON IDEAS OF PROJECT TO BE DEVELOPED TO IMPROVE CLINICAL PRACTICES WITH AI (goal 10 to 15 ideas to be presented) |
Time and Session |
Group 1: How can ESC accelerate the adoption of AI? (e.g incubator) |
Speakers |
Lead: Enrico Caiani Rapporteur: Alan Fraser |
Time and Session |
Group 2: AI for empowering physicians (e.g: Guideline chat bot) |
Speakers |
Lead: Carlos Pena Gil Rapporteur: Philip Moons |
Time and Session |
Group 3: AI for empowering patients (e.g: virtual Drs) |
Speakers |
Lead: Gerhard Hindricks Rapporteur: Andre Ziegler (Roche) |
Time and Session |
Group 4: Collaboration between Industry and clinicians (e.g : write best practices for the use of AI in clinical trials) |
Speakers |
Lead: Panos Vardas Rapporteur: Sarah Adams (Alnylam) |
Time and Session |
14:30-14:40 Report from breakout session 1 |
Speakers |
Rapporteur: Alan Fraser |
Time and Session |
14:40-14:50 Report from breakout session 2 |
Speakers |
Rapporteur: Philip Moons |
Time and Session |
14:50-15:00 Report from breakout session 3 |
Speakers |
Rapporteur: Andre Ziegler (Roche) |
Time and Session |
15:00-15:10 Report from breakout session 4 |
Speakers |
Rapporteur: Sarah Adams (Alnylam) |
Time and Session |
15:10-15:50 PANEL DISCUSSION and NEXT STEPS |
Time and Session |
15:50-16:20 Coffee Break |
Time and Session |
16:20-19:00 - SESSION 2 MODERATED BY: Folkert Asselbergs and Alexandra Goncalves (BMS) |
Time and Session |
16:20-16:35 Usability by design requirements to enable seamless integration of AI into clinical workflows. The experience of EPIC |
Speakers |
John Rozier (EPIC) |
Time and Session |
16:35-16:50 Guidance for Clinical Trial design for evaluation of GenAI |
Speakers | Spiros Denaxas (by zoom) |
Time and Session |
16:50-17:05 EMA view on regulation, what will be the next steps to adopt AI in clinical practice |
Speakers | Florian Lasch EMA (by zoom) |
Time and Session |
17:05-17:45 BREAKOUT SESSIONS: WHAT MECHANISMS FROM THE ESC PERSPECTIVES SHOULD EXIST TO ENSURE SUCCESSFUL IMPLEMENTATION OF AI? (selection of the best idea per group to develop) |
Time and Session |
Group 1: How can ESC accelerate the adoption of AI? (e.g incubator) |
Speakers |
Lead: Enrico Caiani Rapporteur: Alan Fraser |
Time and Session |
Group 2: AI for empowering physicians (e.g: Guideline chat bot) |
Speakers |
Lead: Carlos Pena Gil Rapporteur: Philip Moons |
Time and Session |
Group 3: AI for empowering patients (e.g: virtual Drs) |
Speakers |
Lead: Gerhard Hindricks Rapporteur: Andre Ziegler (Roche) |
Time and Session |
Group 4: Collaboration between Industry and clinicians (e.g : write best practices for the use of AI in clinical trials) |
Speakers |
Lead: Panos Vardas Rapporteur: Sarah Adams (Alnylam) |
Time and Session |
17:45-17:55 Report from breakout session 1 |
Speakers |
Rapporteur: Alan Fraser |
Time and Session |
17:55-18:05 Report from breakout session 2 |
Speakers |
Rapporteur: Philip Moons |
Time and Session |
18:05-18:15 Report from breakout session 3 |
Speakers |
Rapporteur: Andre Ziegler (Roche) |
Time and Session |
18:15-18:25 Report from breakout session 4 |
Speakers |
Rapporteur: Sarah Adams (Alnylam) |
Time and Session |
18:25-19:00 PANEL DISCUSSION and NEXT STEPS |
Time and Session |
|
Time and Session |
END OF DAY 1 |
Time and Session |
19:45 APERITIF + DINNER |
Speakers |
|
Time and Session |
Speakers |
|---|---|
|
11:30-15:50-SESSION 1 MODERATED BY: Ruben Casado Arroyo and Katarzyna Markiewicz (Philips) |
|
|
11:30-11:35 Welcome from the CRT Chairpersons |
Alexandra Goncalves (BMS) Cecilia Linde |
|
11:35-11:45 Summary of the previous meeting on AI |
Ruben Casado Arroyo Katarzyna Markiewicz (Philips) |
|
11:45-12:00 Agenda overview and expected outcomes |
Guy Spigelman (Amazon Web Services) & meeting facilitator Folkert Asselbergs |
|
12:10-12:30 What are the requirements for evidence generation of AI models to be guideline proof? |
Rohan Khera |
|
12:30-13:30 Buffet Lunch |
|
|
13:30-14:30 BREAKOUT SESSIONS : BRAINSTORM ON IDEAS OF PROJECT TO BE DEVELOPED TO IMPROVE CLINICAL PRACTICES WITH AI (goal 10 to 15 ideas to be presented) |
|
|
Group 1: How can ESC accelerate the adoption of AI? (e.g incubator) |
Lead: Enrico Caiani Rapporteur: Alan Fraser |
|
Group 2: AI for empowering physicians (e.g: Guideline chat bot) |
Lead: Carlos Pena Gil Rapporteur: Philip Moons |
|
Group 3: AI for empowering patients (e.g: virtual Drs) |
Lead: Gerhard Hindricks Rapporteur: Andre Ziegler (Roche) |
|
Group 4: Collaboration between Industry and clinicians (e.g : write best practices for the use of AI in clinical trials) |
Lead: Panos Vardas Rapporteur: Sarah Adams (Alnylam) |
|
14:30-14:40 Report from breakout session 1 |
Rapporteur: Alan Fraser |
|
14:40-14:50 Report from breakout session 2 |
Rapporteur: Philip Moons |
|
14:50-15:00 Report from breakout session 3 |
Rapporteur: Andre Ziegler (Roche) |
|
15:00-15:10 Report from breakout session 4 |
Rapporteur: Sarah Adams (Alnylam) |
|
15:10-15:50 PANEL DISCUSSION and NEXT STEPS |
|
|
15:50-16:20 Coffee Break |
|
|
16:20-19:00 - SESSION 2 MODERATED BY: Folkert Asselbergs and Alexandra Goncalves (BMS) |
|
|
16:20-16:35 Usability by design requirements to enable seamless integration of AI into clinical workflows. The experience of EPIC |
John Rozier (EPIC) |
|
16:35-16:50 Guidance for Clinical Trial design for evaluation of GenAI |
Spiros Denaxas (by zoom) |
|
16:50-17:05 EMA view on regulation, what will be the next steps to adopt AI in clinical practice |
Florian Lasch EMA (by zoom) |
|
17:05-17:45 BREAKOUT SESSIONS: WHAT MECHANISMS FROM THE ESC PERSPECTIVES SHOULD EXIST TO ENSURE SUCCESSFUL IMPLEMENTATION OF AI? (selection of the best idea per group to develop) |
|
|
Group 1: How can ESC accelerate the adoption of AI? (e.g incubator) |
Lead: Enrico Caiani Rapporteur: Alan Fraser |
|
Group 2: AI for empowering physicians (e.g: Guideline chat bot) |
Lead: Carlos Pena Gil Rapporteur: Philip Moons |
|
Group 3: AI for empowering patients (e.g: virtual Drs) |
Lead: Gerhard Hindricks Rapporteur: Andre Ziegler (Roche) |
|
Group 4: Collaboration between Industry and clinicians (e.g : write best practices for the use of AI in clinical trials) |
Lead: Panos Vardas Rapporteur: Sarah Adams (Alnylam) |
|
17:45-17:55 Report from breakout session 1 |
Rapporteur: Alan Fraser |
|
17:55-18:05 Report from breakout session 2 |
Rapporteur: Philip Moons |
|
18:05-18:15 Report from breakout session 3 |
Rapporteur: Andre Ziegler (Roche) |
|
18:15-18:25 Report from breakout session 4 |
Rapporteur: Sarah Adams (Alnylam) |
|
18:25-19:00 PANEL DISCUSSION and NEXT STEPS |
|
|
|
|
|
END OF DAY 1 |
|
|
19:45 APERITIF + DINNER |
|
Day 2: 27 March 2025 08:30–12:30 CEST
Time and Session |
08:30-08:40 Summary of day 1 |
Speakers |
Folkert Asselbergs Rodolphe Katra (Medtronic) |
Time and Session |
08:40 – 12:30 SESSION 2.1: BRIDGING THE GAP BETWEEN RESEARCH, REGULATION AND COMMERCIALIZATION MODERATED BY: CECILIA LINDE AND RODOLPHE KATRA (MEDTRONIC) |
Time and Session |
08:40-08:55 Ecosystem development for responsible AI implementation |
Speakers | Markus Vogel (Microsoft) |
Time and Session |
08:55-09:10 Assessment criteria supporting implementation and reimbursement of responsible AI systems (incl. HTA Labs) |
Speakers | Emily Eaton Turner (NICE) |
Time and Session |
09:10-09:25 How to ensure trustworthiness in AI for healthcare: FUTURE-AI guidelines |
Speakers | Karim Lekadir |
Time and Session |
09:25-09:45 Coffee Break |
Time and Session |
09:45-10:30 BREAKOUT SESSIONS: PRESENT YOUR CONCLUSIONS IN 5 SLIDES |
Time and Session |
Group 1: How can ESC accelerate the adoption of AI ? (e.g incubator) |
Speakers |
Lead: Enrico Caiani Rapporteur: Alan Fraser |
Time and Session |
Group 2: AI for empowering physicians (e.g: Guideline chat bot) |
Speakers |
Lead: Carlos Pena Gil Rapporteur: Philip Moons |
Time and Session |
Group 3: AI for empowering patients (e.g: virtual Drs) |
Speakers |
Lead: Gerhard Hindricks Rapporteur: Andre Ziegler (Roche) |
Time and Session |
Group 4: Collaboration between Industry and clinicians (e.g : write best practices for the use of AI in clinical trials) |
Speakers |
Lead: Panos Vardas Rapporteur: Sarah Adams (Alnylam)
|
Time and Session |
10:30-10:40 Report from breakout session 1 |
Speakers |
Rapporteur: Alan Fraser |
Time and Session |
10:40-10:50 Report from breakout session 2 |
Speakers |
Rapporteur: Philip Moons |
Time and Session |
10:50-11:00 Report from breakout session 3 |
Speakers |
Rapporteur: Andre Ziegler (Roche) |
Time and Session |
11:00-11:10 Report from breakout session 4 |
Speakers |
Rapporteur: Sarah Adams (Alnylam) |
Time and Session |
11:10-12:00 PANEL DISCUSSION and NEXT STEPS |
Speakers |
|
Time and Session |
12:00-12:20 Wrap-up, conclusions |
Speakers |
Folkert Asselbergs Rodolphe Katra (Medtronic) |
Time and Session |
END OF DAY 2 |
Time and Session |
12:30 Buffet Lunch and Departures |
Time and Session |
Speakers |
|---|---|
|
08:30-08:40 Summary of day 1 |
Folkert Asselbergs Rodolphe Katra (Medtronic) |
|
08:40 – 12:30 SESSION 2.1: BRIDGING THE GAP BETWEEN RESEARCH, REGULATION AND COMMERCIALIZATION MODERATED BY: CECILIA LINDE AND RODOLPHE KATRA (MEDTRONIC) |
|
|
08:40-08:55 Ecosystem development for responsible AI implementation |
Markus Vogel (Microsoft) |
|
08:55-09:10 Assessment criteria supporting implementation and reimbursement of responsible AI systems (incl. HTA Labs) |
Emily Eaton Turner (NICE) |
|
09:10-09:25 How to ensure trustworthiness in AI for healthcare: FUTURE-AI guidelines |
Karim Lekadir |
|
09:25-09:45 Coffee Break |
|
|
09:45-10:30 BREAKOUT SESSIONS: PRESENT YOUR CONCLUSIONS IN 5 SLIDES |
|
|
Group 1: How can ESC accelerate the adoption of AI ? (e.g incubator) |
Lead: Enrico Caiani Rapporteur: Alan Fraser |
|
Group 2: AI for empowering physicians (e.g: Guideline chat bot) |
Lead: Carlos Pena Gil Rapporteur: Philip Moons |
|
Group 3: AI for empowering patients (e.g: virtual Drs) |
Lead: Gerhard Hindricks Rapporteur: Andre Ziegler (Roche) |
|
Group 4: Collaboration between Industry and clinicians (e.g : write best practices for the use of AI in clinical trials) |
Lead: Panos Vardas Rapporteur: Sarah Adams (Alnylam)
|
|
10:30-10:40 Report from breakout session 1 |
Rapporteur: Alan Fraser |
|
10:40-10:50 Report from breakout session 2 |
Rapporteur: Philip Moons |
|
10:50-11:00 Report from breakout session 3 |
Rapporteur: Andre Ziegler (Roche) |
|
11:00-11:10 Report from breakout session 4 |
Rapporteur: Sarah Adams (Alnylam) |
|
11:10-12:00 PANEL DISCUSSION and NEXT STEPS |
|
|
12:00-12:20 Wrap-up, conclusions |
Folkert Asselbergs Rodolphe Katra (Medtronic) |
|
END OF DAY 2 |
|
|
12:30 Buffet Lunch and Departures |
|
Biographies
- Prof. Cecilia LINDE, Sweden
- Prof. Alexandra GONCALVES, BMS
- Dr. Sarah ADAMS, Alnylam
- Prof. Folkert Asselbergs, Netherlands
- Prof. Enrico G CAIANI, Italy
- Prof. Ruben CASADO ARROYO, Belgium
- Prof. Alan FRASER, UK
- Prof. Gerhard HINDRICKS, Germany
- Dr. Rodolphe KATRA, Medtronic
- Dr. Rohan KHERA, USA
- Dr. Florian LASCH, Netherlands
- Prof. Karim LEKADIR, Spain
- Dr. Katarzyna MARKIEWICZ, Philips
- Prof. Philip MOON, Belgium
- Prof. Carlos PEÑA GIL. Spain
- Mr. Guy SPIGELMAN, Netherlands
- Prof. Panos VARDAS, Greece
- Dr. André ZIEGLER, Roche Diagnostics
Our mission: To reduce the burden of cardiovascular disease.